Larry E. Westerman

516 total citations
19 papers, 396 citations indexed

About

Larry E. Westerman is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Larry E. Westerman has authored 19 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Immunology. Recurrent topics in Larry E. Westerman's work include Viral gastroenteritis research and epidemiology (5 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (5 papers). Larry E. Westerman is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (5 papers). Larry E. Westerman collaborates with scholars based in United States, Canada and South Africa. Larry E. Westerman's co-authors include Roger I. Glass, Baoming Jiang, Peter E. Jensen, Harold M. McClure, Dominique A. Weber, Jeffrey W. Almond, Amy E. Sears, Jennifer Kissner, Jon R. Gentsch and Thea Kølsen Fischer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Larry E. Westerman

19 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry E. Westerman United States 11 240 105 91 83 75 19 396
Fatima Serhan Switzerland 11 171 0.7× 75 0.7× 39 0.4× 80 1.0× 34 0.5× 23 313
Jérôme Jacques France 12 228 0.9× 176 1.7× 56 0.6× 213 2.6× 23 0.3× 17 418
Nadine Lübke Germany 12 305 1.3× 47 0.4× 25 0.3× 113 1.4× 44 0.6× 46 432
M Yin-Murphy Singapore 13 232 1.0× 283 2.7× 101 1.1× 245 3.0× 52 0.7× 37 526
Beatrice Carlsson Sweden 8 275 1.1× 94 0.9× 31 0.3× 67 0.8× 80 1.1× 9 359
Edith C. Sannella United States 10 215 0.9× 52 0.5× 171 1.9× 470 5.7× 18 0.2× 13 603
Maria Torsellini Italy 17 274 1.1× 57 0.5× 53 0.6× 545 6.6× 57 0.8× 24 649
Sonia Resik Cuba 15 358 1.5× 321 3.1× 69 0.8× 236 2.8× 17 0.2× 43 636
Fem Julia Paladin Philippines 12 308 1.3× 208 2.0× 27 0.3× 145 1.7× 40 0.5× 16 445

Countries citing papers authored by Larry E. Westerman

Since Specialization
Citations

This map shows the geographic impact of Larry E. Westerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Westerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Westerman more than expected).

Fields of papers citing papers by Larry E. Westerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Westerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Westerman. The network helps show where Larry E. Westerman may publish in the future.

Co-authorship network of co-authors of Larry E. Westerman

This figure shows the co-authorship network connecting the top 25 collaborators of Larry E. Westerman. A scholar is included among the top collaborators of Larry E. Westerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry E. Westerman. Larry E. Westerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Bolu, Omotayo, Karen Chang, Michael Mwasekaga, et al.. (2018). Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube. PLoS ONE. 13(8). e0202018–e0202018. 3 indexed citations
3.
Scott, Lesley, Jennifer Campbell, Larry E. Westerman, et al.. (2015). A meta-analysis of the performance of the PimaTM CD4 for point of care testing. BMC Medicine. 13(1). 168–168. 31 indexed citations
4.
Ma, Yanling, Jibao Wang, Yingzhen Su, et al.. (2015). Evaluation of PIMA Point-of-care CD4 Analyzer in Yunnan, China. Chinese Medical Journal. 128(7). 890–895. 7 indexed citations
5.
Bergeron, M., Géraldine Daneau, Tao Ding, et al.. (2012). Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations. PLoS ONE. 7(8). e41166–e41166. 21 indexed citations
6.
Ding, Tao, Nádia Sitoe, Larry E. Westerman, et al.. (2012). Correction: Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations. PLoS ONE. 7(9). 5 indexed citations
7.
Westerman, Larry E., Jonathan Kaplan, Thomas J. Spira, et al.. (2010). A Quality Management Systems Approach for CD4 Testing in Resource-Poor Settings. American Journal of Clinical Pathology. 134(4). 556–567. 13 indexed citations
8.
Benjamin, H., Alison Lee, Edward P. Acosta, et al.. (2006). Field Performance of a Thin-Layer Chromatography Assay for Detection of Nevirapine in Umbilical Cord Blood. HIV Clinical Trials. 7(5). 263–269. 11 indexed citations
9.
Westerman, Larry E., Baoming Jiang, Harold M. McClure, et al.. (2006). Isolation and characterization of a new simian rotavirus, YK-1. Virology Journal. 3(1). 40–40. 15 indexed citations
10.
Lee, Alison, et al.. (2006). Field Performance of a Thin-Layer Chromatography Assay for Detection of Nevirapine in Umbilical Cord Blood. HIV Clinical Trials. 7(5). 263–269. 1 indexed citations
11.
Westerman, Larry E., Harold M. McClure, Baoming Jiang, Jeffrey W. Almond, & Roger I. Glass. (2005). Serum IgG mediates mucosal immunity against rotavirus infection. Proceedings of the National Academy of Sciences. 102(20). 7268–7273. 64 indexed citations
12.
Fischer, Thea Kølsen, Deanna Ashley, Tara Kerin, et al.. (2005). Rotavirus Antigenemia in Patients with Acute Gastroenteritis. The Journal of Infectious Diseases. 192(5). 913–919. 68 indexed citations
13.
Westerman, Larry E., et al.. (2005). Experimental infection of pigtailed macaques with a simian rotavirus, YK‐1. Journal of Medical Virology. 75(4). 616–625. 10 indexed citations
14.
Dennehy, Penelope H., Harry Keyserling, Larry E. Westerman, et al.. (2005). Serum Antibody Responses in Children with Rotavirus Diarrhea Can Serve as Proxy for Protection. Clinical and Vaccine Immunology. 12(2). 273–279. 19 indexed citations
15.
Westerman, Larry E. & Peter E. Jensen. (2000). Protein transfer of the costimulatory molecule, B7-2 (CD86), into tumor membrane liposomes as a novel cell-free vaccine. Journal of Immunological Methods. 236(1-2). 77–87. 3 indexed citations
16.
Kissner, Jennifer, et al.. (2000). A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proceedings of the National Academy of Sciences. 97(4). 1818–1822. 47 indexed citations
17.
Westerman, Larry E., et al.. (2000). Induction of Tumor-Specific Immunity in Mice by Immunization With Reconstituted Tumor Membrane Liposomes Containing Recombinant B7-2 (CD86). Journal of Immunotherapy. 23(4). 456–463. 5 indexed citations
18.
Jensen, Peter E., et al.. (1999). Peptide exchange in MHC molecules. Immunological Reviews. 172(1). 229–238. 55 indexed citations
19.
Runnels, Herbert A., Dominique A. Weber, Joseph Curtis Moore, Larry E. Westerman, & Peter E. Jensen. (1997). Intact proteins can bind to class II histocompatibility molecules with high affinity. Molecular Immunology. 34(6). 471–480. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026